Director/PDMR Shareholding
04 8월 2008 - 3:01PM
UK Regulatory
RNS Number : 5247A
Northwest Biotherapeutics Inc
04 August 2008
For Immediate Release August, 4 2008
Northwest Biotherapeutics
("NWBT" or the "Company")
Director/PDMR Shareholding
Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US), announced that, on July 16, 2008, Toucan Partners LLC advised the
Company that, on July 15, 2008, it had distributed 2,572,710 shares of Northwest's common stock to Linda F. Powers, Chairperson of
Northwest's Board of Directors. Ms. Powers is a managing member and fifty percent owner of Toucan Partners, LLC.
As a result of this transfer, Ms. Powers now directly owns 2,572,710 shares representing 6.05%, and as managing member of Toucan
Partners LLC and Toucan Capital Fund II, LP has an additional indirect interest in 45.42% of, Northwest's issued and outstanding stock.
After this transfer Toucan Partners, LLC owns no shares of NWBT but has a continuing interest in warrants to purchase 8,832,541 shares
of the Company's common stock.
For further information, please contact:
Northwest Biotherapeutics
Anthony P. Deasey, Chief Financial Officer +1 240-497-9024
Buchanan Communications
Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane +44 (0)20 7466 5000
Johnson / Catherine Breen
Collins Stewart
Adam Cowen/Tim Mickley +44 (0)20 7523 8230
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPJMRTMMIMBJP
Northw.Bio Regs (LSE:NWBS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Northw.Bio Regs (LSE:NWBS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Northw.Bio Regs (London Stock Exchange)의 실시간 뉴스: 최근 기사 0
More Northwest Bio. News Articles